FibroBiologics, Inc. Common Stock (FBLG)
FibroBiologics, Inc. (FBLG) is a biotechnology company focused on the development and commercialization of regenerative medicine products derived from human fibroblast cells. The company primarily aims to create innovative therapies for wound healing, tissue repair, and other medical applications by leveraging its proprietary cell-based technology platforms.
Company News
FibroBiologics, a clinical-stage biotechnology company, has demonstrated that fibroblasts administered intravenously can facilitate remyelination in an animal model of Cuprizone-induced demyelination. This finding builds on the company's previous report on remyelination in an experimental autoimmune encephalomyelitis (EAE) animal model, providing...
Shares of Skechers U.S.A., Inc. (NYSE: SKX) shares fell during Friday’s session after the company reported mixed fourth-quarter financial results. Skechers said fourth-quarter revenue increased 4.4% year-over-year to $1.96 billion, which missed the consensus estimate of $2.03 billion, according to Benzinga Pro. The company reported quarterly e...